386 results
Does controlling hypertension with ACEIs or ARBs lower risk of new-onset type 2 diabetes? The EBM Focus team discusses a new meta-analysis aiming to answer this clinical question.
The EBM Focus team at DynaMed® revisits “Ten Things You Need to Know” about COVID-19 heading into the third year of the COVID-19 pandemic.
COVID-19 is associated with coagulopathy and risk for thrombotic complications, but not all patients should get anticoagulation. Here is a new tool from the DynaMed Decisions® team at EBSCO that takes the guess work out of this clinical decision.
Annals of Internal Medicine’s Editor-in-Chief Christine Laine, MD, MPH, FACP shares insights into the benefits of pre-prints and advice for minimizing the potential adverse consequences.
Dynamic Health™ Clinical Editor and Social Worker Lainah Hanson take a deep dive into the river of loss to share how social workers and mental health professionals help facilitate the journey of loss for their clients.
The World Health Organization recently endorsed the first malaria vaccine, but malaria prevention remains a difficult endeavor. DynaMed® Medical Writer Keri Sheehan, Ph.D., explores this new development in malaria prevention.
Molnupiravir is a new antiviral pill to treat COVID-19. Here’s what we know so far.
Match Day 2023 is here. Daniel A. Ostrovsky, MD, FAAP, FACP, Topic Editor at DynaMed and Associate Professor at Duke University, shares how residency training has changed during the COVID pandemic.
This Patient Safety Week, EBSCO Nurse Consultant Dr. Kate ONeill shares how Dynamic Health fosters a culture of patient safety to provide effective, patient-centric care.
Psychedelics including LSD, ketamine, and MDMA are often thought of as recreational drugs, but a growing body of research suggests they may be effective for mood disorders and potentially palliative care.